Understanding the Long-term Safety of mRNA Vaccines: What We Know
Written on
Chapter 1: Introduction to mRNA Vaccine Safety
The apprehension surrounding the Covid-19 mRNA vaccines from Pfizer-BioNTech and Moderna primarily stems from their innovative technology, which lacks extensive long-term safety data. Traditional vaccines, such as inactivated and live-attenuated types, have a long history of use, leading to greater public comfort regarding their safety. This innate risk-averse nature is a fundamental human trait shaped by evolution.
But should we really harbor such doubts about mRNA vaccines?
How mRNA Vaccines Function
The fundamental principle of molecular biology states that DNA is transcribed into messenger RNA (mRNA), which is then translated into proteins. The mRNA vaccine introduces protein-coding mRNA into cells, utilizing the cell's own machinery to produce the intended proteins. However, because mRNA is highly fragile and prone to degradation, it is encapsulated in lipid nanoparticles (LNPs) to enhance stability until it enters the cells.
In the case of the Covid-19 mRNA vaccine, the mRNA encodes the genetic instructions for a modified spike protein of the SARS-CoV-2 virus. The cells, typically muscle cells at the injection site, produce these modified spike proteins, enabling the immune system to develop immunity. When re-exposed to the actual virus, the immune system is primed to respond more effectively.
What Are the Potential Long-term Issues?
The mRNA
The supply of mRNA is limited, and cells cease protein production once the mRNA is depleted. Animal studies indicate that the effects of the mRNA vaccine last only a few days. Additionally, ribonucleases in the body rapidly degrade RNA, including mRNA, acting as a protective mechanism against foreign mRNA influencing cellular protein production. Thus, there is minimal risk of mRNA escaping the cells and causing unforeseen effects.
The mRNA does not alter human DNA, as these two molecules are fundamentally different; DNA is double-stranded while mRNA is single-stranded. Moreover, there are no known transport mechanisms that would facilitate mRNA entering the nucleus where DNA resides.
The Spike Protein
Concerns may arise about potential harm from the spike proteins produced by cells receiving the vaccine. However, spike proteins naturally degrade in the body. If this were a genuine concern, all Covid-19 vaccines would pose similar risks. In truth, the spike protein of the SARS-CoV-2 virus is far more hazardous; an infected person can generate billions of virus particles, each with numerous spike proteins.
The mRNA vaccines include modifications that keep the spike proteins in a 'closed' state, unlike the virus's spike protein, which can open and bind to ACE2 receptors to infect cells. This excessive activation of ACE2 can lead to blood clots, highlighting the real danger posed by the virus, not the vaccine.
The Lipid Nanoparticles (LNPs)
Given mRNA's instability outside cells, LNPs are used to deliver it. However, concerns have arisen regarding the biodistribution of these nanoparticles. Studies in animals have shown that LNPs remain primarily localized at the injection site, lymph nodes, and liver, with only trace amounts reaching other tissues, including the brain. These amounts are too small to be harmful, and no toxicity has been observed.
The structure of the LNPs is neutral, lacking the charge needed to interact with the blood-brain barrier effectively.
The Immune Response
The immune system's response to vaccination can vary significantly among individuals. Factors like age, sex, existing health conditions, genetics, and stress levels can influence how one responds to vaccines. Some individuals, particularly those predisposed to autoimmune diseases, may experience post-vaccine autoimmunity, known as Shoenfeld's syndrome, although this is exceedingly rare.
Symptoms can include fatigue, joint pain, and cognitive issues, but the incidence is less than 0.01% of all vaccinations globally. Other vaccines, like those from AstraZeneca and Johnson & Johnson, have been associated with risks of serious conditions like vaccine-induced thrombotic thrombocytopenia (VITT) and Guillain-Barré syndrome (GBS).
Long-term autoimmune disorders may occur in a very small subset of individuals due to unusual immune reactions. However, any autoimmune effects would likely manifest within a month of vaccination, as the immune system’s response is immediate.
Importantly, the Covid-19 mRNA vaccines have not been linked to GBS, VITT, or other long-term autoimmune disorders.
Chapter 2: Existing Long-term Safety Data
This video discusses recent studies indicating the safety of Covid-19 vaccines while highlighting unanswered questions that remain.
As we approach nearly a year since the emergency use authorization (EUA) of Pfizer and Moderna's mRNA vaccines by the FDA, several large-scale studies have emerged. These studies suggest a potential increase in risks for conditions like anaphylaxis, herpes zoster infections, and myocarditis. However, most of these risks are short-term, with myocarditis being the most consistent concern, particularly in younger males.
The CDC has emphasized that despite these risks, the benefits of mRNA vaccines outweigh their potential harms across all age groups. While myocarditis can lead to hospitalization, it typically resolves quickly with standard treatments.
Moreover, unlike the mRNA vaccines, SARS-CoV-2 presents a genuine threat, with the virus capable of causing long-term health issues, including chronic fatigue syndrome and lung scarring.
We have extensive long-term safety data on mRNA vaccine technology, stemming from trials dating back to 2009, which have consistently shown positive safety profiles. Experts agree that while absolute certainty in medicine is unattainable, there is ample evidence to support the safety of mRNA vaccines.
In conclusion, while there remains a slight possibility of long-term cardiovascular issues from post-vaccine myocarditis, there are no mechanisms by which mRNA vaccines can cause delayed problems.
If you found this information valuable, consider subscribing to my Medium email list. Your support helps sustain science writing, allowing me to continue providing insights on critical health topics.